Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Sales (2016 - 2025)

Historic Return on Sales for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.24%.

  • Cumberland Pharmaceuticals' Return on Sales fell 700.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.08%, marking a year-over-year increase of 2100.0%. This contributed to the annual value of 0.17% for FY2024, which is 100.0% down from last year.
  • According to the latest figures from Q3 2025, Cumberland Pharmaceuticals' Return on Sales is 0.24%, which was down 700.0% from 0.07% recorded in Q2 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Return on Sales peaked at 0.11% during Q1 2025, and registered a low of 0.67% during Q4 2023.
  • Moreover, its 5-year median value for Return on Sales was 0.02% (2023), whereas its average is 0.07%.
  • Within the past 5 years, the most significant YoY rise in Cumberland Pharmaceuticals' Return on Sales was 4900bps (2024), while the steepest drop was -2400bps (2024).
  • Over the past 5 years, Cumberland Pharmaceuticals' Return on Sales (Quarter) stood at 0.06% in 2021, then tumbled by -80bps to 0.01% in 2022, then crashed by -5616bps to 0.67% in 2023, then soared by 73bps to 0.18% in 2024, then decreased by -29bps to 0.24% in 2025.
  • Its Return on Sales stands at 0.24% for Q3 2025, versus 0.07% for Q2 2025 and 0.11% for Q1 2025.